SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : OCGT again

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Stock Puppy who wrote (18)8/16/1996 4:22:00 PM
From: Jack Ucci   of 283
 
I did not mean to be so critical. I really do need another view of OCGT and while it might not seem so, I am appreciative of your posts. As for OCGT's action today certainly it showed weakness throughout the day. Comming down though on low volume. Each time we get a spike up, it is followed by weakness. I am beginning to think if no good news appears soon, this stock could go back to 1, which I would view as a great buying opportunity. Maybe I should revise my strategy here: instead of waiting for 2+, get out just below 2, then buy again at a lower price.

On a different note I was told that Smith Barney is a marketmaker in OCGT. Josephthal, Lyon, and Ross used to be but I don't know if they still are.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext